Pilot Sleep Intervention to Improve Diabetes Management in School-Aged Children
- Conditions
- Type 1 Diabetes Mellitus
- Registration Number
- NCT03397147
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
Evaluate the feasibility, acceptability, and preliminary efficacy of a sleep-promoting intervention for school-aged children with type 1 diabetes and their caregivers in a pilot randomized trial. The primary outcome is improvements in child sleep, and secondary outcomes include glycemic control (HbA1c, % in range), improvements in parent sleep, parental distress, and child behavior problems.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- child between 5-9 years of age
- child have been diagnosed with type 1 diabetes for at least 12 months
- caregiver lives with child
- caregiver can read/speak English
- child has other major health problems or sleep disorders other than insufficient sleep or insomnia
- participating in other intervention studies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Child Sleep Quality 3 months Child sleep quality (measured with Child Sleep Habits Questionnaire)
Child Sleep Duration 3 months Child sleep duration (measured with actigraphy)
- Secondary Outcome Measures
Name Time Method Parent Sleep Quality 3 months and sleep quality (measured with Pittsburgh Sleep Quality Index)
Child Behavior Problems 3 months Behavior problems measured with the Child Behavior Checklist (CBCL)
Parental Fear of Hypoglycemia 3 months Parental fear of hypoglycemia (Hypoglycemic Fear Survey, Worry subscale)
Glycemic Control 3 months HbA1c, % glucose values in range
Parent Sleep Duration 3 months Parent sleep duration (measured with actigraphy)
Parental Diabetes Distress 3 months Diabetes distress (Problem Area In Diabetes - Parental Version Revised)
Parental Well-being 3 months Well-Being Index (World Health Organization Five Well-Being Index, WHO-5)
Trial Locations
- Locations (1)
Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States
Vanderbilt University Medical Center🇺🇸Nashville, Tennessee, United States